BR9806540A - Pharmaceutical composition for treatment of hemophilia or asthmatic bronchitis - Google Patents

Pharmaceutical composition for treatment of hemophilia or asthmatic bronchitis

Info

Publication number
BR9806540A
BR9806540A BR9806540-8A BR9806540A BR9806540A BR 9806540 A BR9806540 A BR 9806540A BR 9806540 A BR9806540 A BR 9806540A BR 9806540 A BR9806540 A BR 9806540A
Authority
BR
Brazil
Prior art keywords
hemophilia
treatment
pharmaceutical composition
asthmatic bronchitis
poly
Prior art date
Application number
BR9806540-8A
Other languages
Portuguese (pt)
Other versions
BR9806540C1 (en
Inventor
Akira Yoshitome
Eiji Sato
Original Assignee
Akira Yoshitome
Eiji Sato
Naul Ozi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akira Yoshitome, Eiji Sato, Naul Ozi filed Critical Akira Yoshitome
Priority to BR9806540-8A priority Critical patent/BR9806540C1/en
Priority to AU45943/99A priority patent/AU4594399A/en
Priority to PCT/BR1999/000042 priority patent/WO1999063928A2/en
Publication of BR9806540A publication Critical patent/BR9806540A/en
Publication of BR9806540C1 publication Critical patent/BR9806540C1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composição farmacêutica para tratamento de hemofilia e bronquite asmática, que possibilita a formação das cadeias ß-4-poly-N-acetyl-D-glucosamine, com intervalo de 40% a 5% da cadeia molecular fracionada e ß-1,4-poly-D-glucosamine, com intervalo de 60% a 95% da cadeia molecular fracionada, esta composição é útil no tratamento ou alívio das hemorragias internas e externas dos portadores de hemofilia e da doença respiratoria bronquite asmática.Pharmaceutical composition for the treatment of hemophilia and asthmatic bronchitis, which allows the formation of ß-4-poly-N-acetyl-D-glucosamine chains, with a range of 40% to 5% of the fractionated molecular chain and ß-1,4-poly -D-glucosamine, with an interval of 60% to 95% of the fractionated molecular chain, this composition is useful in the treatment or relief of internal and external hemorrhages in people with hemophilia and respiratory disease, asthmatic bronchitis.

BR9806540-8A 1998-06-09 1998-06-09 Pharmaceutical product for the treatment of hemophilia and asthmatic bronchitis BR9806540C1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BR9806540-8A BR9806540C1 (en) 1998-06-09 1998-06-09 Pharmaceutical product for the treatment of hemophilia and asthmatic bronchitis
AU45943/99A AU4594399A (en) 1998-06-09 1999-06-09 Pharmaceutical product for hemophilia and asthmatic bronchitis treatment
PCT/BR1999/000042 WO1999063928A2 (en) 1998-06-09 1999-06-09 Pharmaceutical product for hemophilia and asthmatic bronchitis treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR9806540-8A BR9806540C1 (en) 1998-06-09 1998-06-09 Pharmaceutical product for the treatment of hemophilia and asthmatic bronchitis

Publications (2)

Publication Number Publication Date
BR9806540A true BR9806540A (en) 2001-03-06
BR9806540C1 BR9806540C1 (en) 2001-05-08

Family

ID=4071490

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9806540-8A BR9806540C1 (en) 1998-06-09 1998-06-09 Pharmaceutical product for the treatment of hemophilia and asthmatic bronchitis

Country Status (3)

Country Link
AU (1) AU4594399A (en)
BR (1) BR9806540C1 (en)
WO (1) WO1999063928A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK505488D0 (en) * 1987-12-21 1988-09-09 Bar Shalom Daniel MEDIUM AND USE OF SAME
WO1996041818A1 (en) * 1995-06-09 1996-12-27 Drohan William N Chitin hydrogels, methods of their production and use
WO1998004133A1 (en) * 1996-07-29 1998-02-05 Cavalier Pharmaceuticals Methods of treating asthma with o-desulfated heparin

Also Published As

Publication number Publication date
BR9806540C1 (en) 2001-05-08
WO1999063928A3 (en) 2000-02-03
WO1999063928A2 (en) 1999-12-16
AU4594399A (en) 1999-12-30

Similar Documents

Publication Publication Date Title
BR0313371A (en) Compound, use of a compound and disease treatment method
DZ3165A1 (en) Food or pharmaceutical composition used to prevent or treat hyperoxaluria.
BRPI0410503A (en) use of ivermectin for the manufacture of a topical pharmaceutical composition, topical composition and use of the composition
BR9711108A (en) Compounds that are new 1,4-disubstituted piperidine derivatives pharmaceutical composition and processes for the treatment or prophylaxis of diseases associated with muscarinic receptors and for the preparation of 1,4-disubstituted piperidine derivatives containing fluorine
PT754176E (en) NEW CARBAMATES AND UREIAS AS MODIFIERS OF RESISTANCE TO MULTIPLE DRUGS
BR0310092A (en) Combination of Organic Compounds
BR9611861A (en) Treatment of hiv central nervous system effects with vx-478 alone or in combination with azt or 3tc
BR0309095A (en) Use of osteoprotegerin for the treatment and / or prevention of fibrotic disease.
BR0313239A (en) Compound, pharmaceutical composition, and methods of treating or preventing pain and inflammation and disease
BR9914735A (en) Process for sepsis treatment
BR9908510A (en) Use of a compound, compound, process for preparing a compound, pharmaceutical composition, and process for treating a patient suffering from, or at risk for, a mycobacterial disease
EE9900470A (en) Use of zinc hyaluronate against peptic ulcer
BR9810703A (en) Pharmaceutical composition, and processes for preparing it, and for treating a platelet aggregation disorder
BR9809678A (en) Triptolyte derivatives useful in the treatment of autoimmune diseases
BR0112547A (en) Process for finding compounds that are suitable for obesity treatment and / or prophylaxis
BR9814945A (en) Use of phanquinone for the treatment of alzheimer's disease, pharmaceutical composition and kit
BR9712466A (en) Application of adamantanamines or compounds of similar structure to combat borne disease virus and for the prophylaxis and treatment of emotional diseases and other disorders linked to infections of human and animal bd virus
BR9908716A (en) Treatment of sexual dysfunction in certain groups of patients
BR9913337A (en) Derivatives tan-1057
BR0107960A (en) Treatment of allergic and inflammatory conditions
BR9812531A (en) Combination of components, pharmaceutical preparation, production thereof, and use of the combination or pharmaceutical preparation
BR9809673A (en) Triptolide derivatives useful in the treatment of autoimmune diseases
YU39598A (en) The use of dulloxetine and its pharmaceutical composition
BR9806540A (en) Pharmaceutical composition for treatment of hemophilia or asthmatic bronchitis
BR9712307A (en) Pyrazolinones for the treatment of weakened potency

Legal Events

Date Code Title Description
PC Transfer

Free format text: AKYRA YOSHITOME/EIJI SATO/NUAL OZI (BR/ES)

HHT Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication

Free format text: REFERENCIA: RPI 1542 DE 25/07/2000 - COD. 25.1 ITEM (71)

B08F Application fees: dismissal - article 86 of industrial property law

Free format text: ADDITIONAL INVENTOR S CERTIFICATE: REFERENTE A 7A E 8A ANUIDADES.

B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1887 DE 06/03/2007.

Free format text: ADDITIONAL INVENTOR S CERTIFICATE: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1838 DE 28/03/2006.